Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS.

Deiva K, Huppke P, Banwell B, Chitnis T, Gärtner J, Krupp L, Waubant E, Stites T, Pearce GL, Merschhemke M.

J Neurol Neurosurg Psychiatry. 2019 Aug 29. pii: jnnp-2019-321124. doi: 10.1136/jnnp-2019-321124. [Epub ahead of print]

2.

Environmental and genetic risk factors for MS: an integrated review.

Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A.

Ann Clin Transl Neurol. 2019 Aug 7. doi: 10.1002/acn3.50862. [Epub ahead of print] Review.

3.

Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.

Pardo S, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E, Levy M.

Mult Scler Relat Disord. 2019 Aug;33:A1-A2. doi: 10.1016/j.msard.2019.07.001. Epub 2019 Jul 2. No abstract available.

PMID:
31324299
4.

A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.

Manguinao M, Krysko KM, Maddike S, Rutatangwa A, Francisco C, Hart J, Chong J, Graves JS, Waubant E.

Mult Scler Relat Disord. 2019 Jul 8;35:50-54. doi: 10.1016/j.msard.2019.07.004. [Epub ahead of print]

PMID:
31319355
5.

miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS.

Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF; US Network of Pediatric MS Centers.

Ann Clin Transl Neurol. 2019 May 15;6(6):1053-1061. doi: 10.1002/acn3.786. eCollection 2019 Jun.

6.

One size doesn't fit all.

Lechner-Scott J, Giovannoni G, Hawkes C, Levy M, Waubant E.

Mult Scler Relat Disord. 2019 Jun;31:A1-A2. doi: 10.1016/j.msard.2019.04.034. Epub 2019 Apr 30. No abstract available.

PMID:
31159999
7.

Introducing the International Women in Multiple Sclerosis network.

Jokubaitis VG, Pröbstel AK, Arrambide G, Costello F, Waubant E.

Lancet Neurol. 2019 Jun;18(6):521. doi: 10.1016/S1474-4422(19)30160-7. No abstract available.

PMID:
31122489
8.

Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis.

Zipp F, Oh J, Fragoso YD, Waubant E.

Nat Rev Neurol. 2019 Aug;15(8):441-445. doi: 10.1038/s41582-019-0194-0. Review.

PMID:
31086264
9.

Vitamin D genes influence MS relapses in children.

Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant E.

Mult Scler. 2019 May 13:1352458519845842. doi: 10.1177/1352458519845842. [Epub ahead of print]

PMID:
31081484
10.

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.

Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T; IPMSSG.

Neurology. 2019 May 28;92(22):e2538-e2549. doi: 10.1212/WNL.0000000000007572. Epub 2019 May 1.

11.

Three suggestions to decrease the financial burden of MS treatments.

Waubant E, Giovannoni G, Hawkes C, Lechner-Scott J, Levy M.

Mult Scler Relat Disord. 2019 May;30:A1. doi: 10.1016/j.msard.2019.03.023. No abstract available.

PMID:
30987755
12.

Mind the gap: Quantifying gender representation as a first step to solve the problem?

Waubant E, Gilmore W.

Neurology. 2019 Apr 9;92(15):698-699. doi: 10.1212/WNL.0000000000007268. Epub 2019 Mar 20. No abstract available.

PMID:
30894445
13.

Acute flaccid myelitis in the 21st century: reminiscence of poliomyelitis or a new emergent disease.

Levy M, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E.

Mult Scler Relat Disord. 2019 Apr;29:A1-A2. doi: 10.1016/j.msard.2019.03.007. No abstract available. Erratum in: Mult Scler Relat Disord. 2019 Jul;32:138.

PMID:
30885376
14.

Pediatric glial fibrillary acidic protein meningoencephalomyelitis: A case report and review of the literature.

Francisco C, Meddles K, Waubant E.

Mult Scler Relat Disord. 2019 Apr;29:148-152. doi: 10.1016/j.msard.2018.12.008. Epub 2018 Dec 7. Review.

PMID:
30885369
15.

Multiple Sclerosis and Vitamin D - Caviar or a Dog's Dinner?

Hawkes C, Giovannoni G, Lechner-Scott J, Levy M, Waubant E.

Mult Scler Relat Disord. 2019 Feb;28:A1-A2. doi: 10.1016/j.msard.2019.02.015. No abstract available.

PMID:
30823982
16.

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF.

PLoS Genet. 2019 Jan 17;15(1):e1007808. doi: 10.1371/journal.pgen.1007808. eCollection 2019 Jan.

17.

Should our treatment target in MS include the intrathecal plasma cell response?

Giovannoni G, Hawkes C, Levy M, Lechner-Scott J, Waubant E.

Mult Scler Relat Disord. 2019 Jan;27:A1-A2. doi: 10.1016/j.msard.2018.12.039. No abstract available.

PMID:
30642567
18.

Vaccines and disease-modifying treatments.

Waubant E, Giovannoni G, Hawkes C, Levy M.

Mult Scler Relat Disord. 2018 Nov;26:A1-A2. doi: 10.1016/j.msard.2018.10.017. Epub 2018 Oct 24. No abstract available.

PMID:
30573174
19.

Several household chemical exposures are associated with pediatric-onset multiple sclerosis.

Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E; U.S. Network of Pediatric Multiple Sclerosis Centers.

Ann Clin Transl Neurol. 2018 Oct 9;5(12):1513-1521. doi: 10.1002/acn3.663. eCollection 2018 Dec.

20.

Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.

Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp L.

J Child Neurol. 2018 Dec 17:883073818815041. doi: 10.1177/0883073818815041. [Epub ahead of print]

PMID:
30556452
21.

Subclinical Saccadic Eye Movement Dysfunction in Pediatric Multiple Sclerosis.

Yousef A, Devereux M, Gourraud PA, Jonzzon S, Suleiman L, Waubant E, Green A, Graves JS.

J Child Neurol. 2019 Jan;34(1):38-43. doi: 10.1177/0883073818807787. Epub 2018 Nov 21.

PMID:
30463467
22.

Body mass index, but not vitamin D status, is associated with brain volume change in MS.

Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D.

Neurology. 2018 Dec 11;91(24):e2256-e2264. doi: 10.1212/WNL.0000000000006644. Epub 2018 Nov 14.

PMID:
30429274
23.

Puberty onset and pediatric multiple sclerosis activity in boys.

Young B, Waubant E, Lulu S, Graves J.

Mult Scler Relat Disord. 2019 Jan;27:184-187. doi: 10.1016/j.msard.2018.10.014. Epub 2018 Oct 22.

PMID:
30390578
24.

Refining the Nosology of Antigen-Specific Diseases Within the Spectrum of Neuromyelitis Optica.

Levy M, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2018 Oct;25:A1-A2. doi: 10.1016/j.msard.2018.09.027. No abstract available.

PMID:
30384960
25.

Heterogeneity in association of remote herpesvirus infections and pediatric MS.

Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E; US Network of Pediatric MS Centers.

Ann Clin Transl Neurol. 2018 Sep 17;5(10):1222-1228. doi: 10.1002/acn3.636. eCollection 2018 Oct.

26.

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course.

Nourbakhsh B, Bhargava P, Tremlett H, Hart J, Graves J, Waubant E.

Ann Clin Transl Neurol. 2018 Sep 27;5(10):1211-1221. doi: 10.1002/acn3.637. eCollection 2018 Oct.

27.

Urban air quality and associations with pediatric multiple sclerosis.

Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman AT.

Ann Clin Transl Neurol. 2018 Sep 27;5(10):1146-1153. doi: 10.1002/acn3.616. eCollection 2018 Oct.

28.

Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study.

Bartolini L, Piras E, Sullivan K, Gillen S, Bumbut A, Lin CM, Leibovitch EC, Graves JS, Waubant EL, Chamberlain JM, Gaillard WD, Jacobson S.

Front Neurol. 2018 Oct 5;9:834. doi: 10.3389/fneur.2018.00834. eCollection 2018.

29.

Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US.

Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E; US Network of Pediatric MS Centers.

Neurology. 2018 Nov 6;91(19):e1778-e1787. doi: 10.1212/WNL.0000000000006471. Epub 2018 Oct 17.

PMID:
30333163
30.

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.

Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group.

N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149.

31.

Editors' Welcome.

Hawkes CH, Giovannoni G, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Aug;24:A1-A2. doi: 10.1016/j.msard.2018.08.010. No abstract available.

PMID:
30190056
32.

Is cognitive impairment in multiple sclerosis reversible?

Giovannoni G, Hawkes C, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Jul;23:A1. doi: 10.1016/j.msard.2018.07.007. No abstract available.

PMID:
30049507
33.

Diagnosing and caring for MS in Haiti.

Waubant E, Berkowitz A, Giovannoni G, Hawkes C, Levy M.

Mult Scler Relat Disord. 2018 May;22:A1-A2. doi: 10.1016/j.msard.2018.05.009. No abstract available.

PMID:
29807822
34.

Editors' Welcome: Pregnancy and progressive multifocal leukoencephalopathy.

Levy M, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2018 Apr;21:A1-A2. doi: 10.1016/j.msard.2018.03.016. No abstract available.

PMID:
29724377
35.

Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis.

Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS; Network of Pediatric Multiple Sclerosis Centers.

Mult Scler Relat Disord. 2018 May;22:103-107. doi: 10.1016/j.msard.2018.03.015. Epub 2018 Mar 26.

36.

Are the high-costs of MS disease-modifying therapies justified?

Giovannoni G, Hawkes C, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Feb;20:A3-A5. doi: 10.1016/j.msard.2018.02.018. No abstract available.

PMID:
29579631
37.

Editors' Welcome.

Hawkes C, Giovannoni G, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Feb;20:A1-A2. doi: 10.1016/j.msard.2018.02.017. No abstract available.

PMID:
29579630
38.

Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls.

Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, Jacobson S.

Mult Scler. 2019 Apr;25(5):644-652. doi: 10.1177/1352458518765654. Epub 2018 Mar 23.

PMID:
29569515
39.

Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawal.

Chong J, Cohen M, Waubant E.

Mult Scler Relat Disord. 2018 Feb;20:178-180. doi: 10.1016/j.msard.2018.01.025. Epub 2018 Mar 20.

PMID:
29414294
40.

Editors' Welcome.

Giovannoni G, Hawkes C, Levy M, Lublin F, Waubant E.

Mult Scler Relat Disord. 2018 Jan;19:A1-A2. doi: 10.1016/j.msard.2018.01.004. No abstract available.

PMID:
29409600
41.

The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults.

Graves JS, Barcellos LF, Simpson S, Belman A, Lin R, Taylor BV, Ponsonby AL, Dwyer T, Krupp L, Waubant E, van der Mei IAF.

Mult Scler Relat Disord. 2018 Jan;19:161-165. doi: 10.1016/j.msard.2017.10.008. Epub 2017 Oct 14.

42.

Gut microbiome and pediatric multiple sclerosis.

Tremlett H, Waubant E.

Mult Scler. 2018 Jan;24(1):64-68. doi: 10.1177/1352458517737369. Review.

PMID:
29307301
43.

Effect of puberty on multiple sclerosis risk and course.

Waubant E.

Mult Scler. 2018 Jan;24(1):32-35. doi: 10.1177/1352458517737393. Review.

PMID:
29307289
44.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
45.

Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2018 Apr;27(4):1117. doi: 10.1007/s11136-017-1773-4.

46.

Ovarian aging is associated with gray matter volume and disability in women with MS.

Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A; University of California, San Francisco MS-EPIC Team,, Bacchetti P, Hauser SL, Oksenberg JR.

Neurology. 2018 Jan 16;90(3):e254-e260. doi: 10.1212/WNL.0000000000004843. Epub 2017 Dec 22.

47.

Editors' Welcome.

Waubant E, Giovannoni G, Hawkes C, Lublin F.

Mult Scler Relat Disord. 2017 Nov;18:A1-A2. doi: 10.1016/j.msard.2017.10.016. No abstract available.

PMID:
29141832
48.

Examining the contributions of environmental quality to pediatric multiple sclerosis.

Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E; U.S. Network of Pediatric MS Centers.

Mult Scler Relat Disord. 2017 Nov;18:164-169. doi: 10.1016/j.msard.2017.09.004. Epub 2017 Sep 7.

49.

Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.

Nourbakhsh B, Revirajan N, Waubant E.

Contemp Clin Trials. 2018 Jan;64:67-76. doi: 10.1016/j.cct.2017.11.005. Epub 2017 Nov 4.

PMID:
29113955
50.

Editors' Welcome.

Lublin F, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2017 Oct;17:A1-A2. doi: 10.1016/j.msard.2017.09.025. No abstract available.

PMID:
29055486

Supplemental Content

Loading ...
Support Center